171 related articles for article (PubMed ID: 31628851)
1. The added benefit of transvaginal sonography in the clinical staging of cervical carcinoma.
Goldberg Y; Siegler Y; Segev Y; Mandel R; Siegler E; Auslander R; Lavie O
Acta Obstet Gynecol Scand; 2020 Mar; 99(3):312-316. PubMed ID: 31628851
[TBL] [Abstract][Full Text] [Related]
2. The role of ultrasound in primary workup of cervical cancer staging (ESGO, ESTRO, ESP cervical cancer guidelines).
Fischerová D; Cibula D
Ceska Gynekol; 2019; 84(1):40-48. PubMed ID: 31213057
[TBL] [Abstract][Full Text] [Related]
3. What Is the Role of Imaging at Primary Diagnostic Work-Up in Uterine Cervical Cancer?
Haldorsen IS; Lura N; Blaakær J; Fischerova D; Werner HMJ
Curr Oncol Rep; 2019 Jul; 21(9):77. PubMed ID: 31359169
[TBL] [Abstract][Full Text] [Related]
4. Value of magnetic resonance and ¹⁸FDG PET-CT in predicting tumor response and resectability of primary locally advanced cervical cancer after treatment with intensity-modulated arc therapy: a prospective pathology-matched study.
Vandecasteele K; Delrue L; Lambert B; Makar A; Lambein K; Denys H; Tummers P; Van den Broecke R; Villeirs G; De Meerleer G
Int J Gynecol Cancer; 2012 May; 22(4):630-7. PubMed ID: 22237382
[TBL] [Abstract][Full Text] [Related]
5. Patterns of failure after use of (18)F-FDG PET/CT in integration of extended-field chemo-IMRT and 3D-brachytherapy plannings for advanced cervical cancers with extensive lymph node metastases.
Chung YL; Horng CF; Lee PI; Chen FL
BMC Cancer; 2016 Mar; 16():179. PubMed ID: 26940959
[TBL] [Abstract][Full Text] [Related]
6. Value of [
Li K; Sun H; Lu Z; Xin J; Zhang L; Guo Y; Guo Q
Eur J Radiol; 2018 Sep; 106():160-166. PubMed ID: 30150039
[TBL] [Abstract][Full Text] [Related]
7. HIV status does not have an impact on positron emission tomography-computed tomography (PET-CT) findings or radiotherapy treatment recommendations in patients with locally advanced cervical cancer.
Simonds H; Botha MH; Ellmann A; Warwick J; Doruyter A; Neugut AI; Van Der Merwe H; Jacobson JS
Int J Gynecol Cancer; 2019 Oct; 29(8):1252-1257. PubMed ID: 31413068
[TBL] [Abstract][Full Text] [Related]
8. Detection of hematogenous bone metastasis in cervical cancer: 18F-fluorodeoxyglucose-positron emission tomography versus computed tomography and magnetic resonance imaging.
Liu FY; Yen TC; Chen MY; Lai CH; Chang TC; Chou HH; Hong JH; Chen YR; Ng KK
Cancer; 2009 Dec; 115(23):5470-80. PubMed ID: 19739235
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study.
Caobelli F; Alongi P; Evangelista L; Picchio M; Saladini G; Rensi M; Geatti O; Castello A; Laghai I; Popescu CE; Dolci C; Crivellaro C; Seghezzi S; Kirienko M; De Biasi V; Cocciolillo F; Quartuccio N;
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):404-13. PubMed ID: 26381775
[TBL] [Abstract][Full Text] [Related]
10. Value of PET-CT in avoiding multimodality therapy in operable cervical cancer.
Goyal BK; Singh H; Kapur K; Duggal BS; Jacob MJ
Int J Gynecol Cancer; 2010 Aug; 20(6):1041-5. PubMed ID: 20683414
[TBL] [Abstract][Full Text] [Related]
11. Comparison of elastography based on transvaginal ultrasound and MRI in assessing parametrial invasion of cervical cancer.
Ma X; Li Q; Wang JL; Shao J; Zhu YC; Ding W; Zhang HS; Wang HY; Shen JK
Clin Hemorheol Microcirc; 2017; 66(1):27-35. PubMed ID: 28211804
[TBL] [Abstract][Full Text] [Related]
12. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer.
Driscoll DO; Halpenny D; Johnston C; Sheehy N; Keogan M
Abdom Imaging; 2015 Jan; 40(1):127-33. PubMed ID: 25015401
[TBL] [Abstract][Full Text] [Related]
14. Isolated mediastinal lymph node false positivity of [18F]-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical cancer.
Onal C; Oymak E; Findikcioglu A; Reyhan M
Int J Gynecol Cancer; 2013 Feb; 23(2):337-42. PubMed ID: 23358181
[TBL] [Abstract][Full Text] [Related]
15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
16. Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area.
Boughanim M; Leboulleux S; Rey A; Pham CT; Zafrani Y; Duvillard P; Lumbroso J; Haie-Meder C; Schlumberger M; Morice P
J Clin Oncol; 2008 May; 26(15):2558-61. PubMed ID: 18487573
[TBL] [Abstract][Full Text] [Related]
17. Correlation between FDG uptake by PET/CT and the expressions of glucose transporter type 1 and hexokinase II in cervical cancer.
Tong SY; Lee JM; Ki KD; Choi YJ; Seol HJ; Lee SK; Huh CY; Kim GY; Lim SJ
Int J Gynecol Cancer; 2012 May; 22(4):654-8. PubMed ID: 22398711
[TBL] [Abstract][Full Text] [Related]
18. Standardized uptake value and metabolic tumor volume measured by ¹⁸F FDG PET/CT are sensitive biomarkers for the presence of lymph node metastasis in patients with cervical carcinoma.
Vural GU; Akkas BE; Demirel BB
Rev Esp Med Nucl Imagen Mol; 2014; 33(5):268-73. PubMed ID: 25018135
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of preoperative positron emission tomography-computed tomography (PET-CT) for detection of lymph node metastasis in cervical and endometrial cancer: clinical and pathological factors influencing it.
Nogami Y; Banno K; Irie H; Iida M; Kisu I; Masugi Y; Tanaka K; Tominaga E; Okuda S; Murakami K; Aoki D
Jpn J Clin Oncol; 2015 Jan; 45(1):26-34. PubMed ID: 25368102
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the Role of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scanning in the Staging of Patients With Stage IIIB Cervical Carcinoma and the Impact on Treatment Decisions.
Morkel M; Ellmann A; Warwick J; Simonds H
Int J Gynecol Cancer; 2018 Feb; 28(2):379-384. PubMed ID: 29324535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]